1. Home
  2. STKE vs ANEB Comparison

STKE vs ANEB Comparison

Compare STKE & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKE
  • ANEB
  • Stock Information
  • Founded
  • STKE 2002
  • ANEB 2020
  • Country
  • STKE Canada
  • ANEB United States
  • Employees
  • STKE N/A
  • ANEB N/A
  • Industry
  • STKE
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKE
  • ANEB Health Care
  • Exchange
  • STKE Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • STKE 95.8M
  • ANEB 111.8M
  • IPO Year
  • STKE N/A
  • ANEB 2021
  • Fundamental
  • Price
  • STKE $3.78
  • ANEB $2.75
  • Analyst Decision
  • STKE
  • ANEB Buy
  • Analyst Count
  • STKE 0
  • ANEB 2
  • Target Price
  • STKE N/A
  • ANEB $8.00
  • AVG Volume (30 Days)
  • STKE 807.3K
  • ANEB 25.6K
  • Earning Date
  • STKE 01-29-2026
  • ANEB 11-12-2025
  • Dividend Yield
  • STKE N/A
  • ANEB N/A
  • EPS Growth
  • STKE N/A
  • ANEB N/A
  • EPS
  • STKE N/A
  • ANEB N/A
  • Revenue
  • STKE $14,342,517.00
  • ANEB N/A
  • Revenue This Year
  • STKE $43.15
  • ANEB N/A
  • Revenue Next Year
  • STKE $39.60
  • ANEB N/A
  • P/E Ratio
  • STKE N/A
  • ANEB N/A
  • Revenue Growth
  • STKE N/A
  • ANEB N/A
  • 52 Week Low
  • STKE $3.06
  • ANEB $0.80
  • 52 Week High
  • STKE $34.32
  • ANEB $3.42
  • Technical
  • Relative Strength Index (RSI)
  • STKE N/A
  • ANEB 60.11
  • Support Level
  • STKE N/A
  • ANEB $2.50
  • Resistance Level
  • STKE N/A
  • ANEB $2.76
  • Average True Range (ATR)
  • STKE 0.00
  • ANEB 0.13
  • MACD
  • STKE 0.00
  • ANEB 0.03
  • Stochastic Oscillator
  • STKE 0.00
  • ANEB 75.00

About STKE Sol Strategies Inc. Common Shares

Sol Strategies Inc is engaged in investing in blockchain technologies and crypto currencies. Company executes its Investment Objective through three lines of effort: Treasury management: Maintaining a core portfolio of cryptocurrencies for long-term growth, enhanced with risk management strategies to minimize volatility, and generating yield through lending, staking, and liquidity provisioning; Private equity focused on early stage companies in the DeFi and blockchain sectors; and Active investments to generate yield through strategic activities, including Bitcoin mining and stalking and validating Solana.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.

Share on Social Networks: